Portugal to cover all dialysis spending

4 February 2008

The Portuguese Ministry of Health and the national association of privately-run dialysis centers, Anadial, have agreed on a new bundled reimbursement model for hemodialysis patients.

The Comprehensive Price Payment model is an integrated system which will cover reimbursement for all necessary dialysis services, related products, laboratory services and the administration of other medical tests and necessary drugs (eg, for anemia management, bone management, blood pressure, etc).

In 2007, dialysis specialist Fresenius Medical generated revenues of $128.0 million in Portugal (1.3% of estimated group revenues last year), and the company expects the reimbursement rate to increase 50% following the introduction of a bundled rate, note analysts at Lehman Brothers. Portugal is the first European country to adopt a bundled reimbursement model in dialysis.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight